No Detail Found!

Pathological insights to Polycystic Ovary Syndrome: Crosslinking Decreased Brain- Derived Neurotrophic Factor (BDNF) levels with a multi-system disorder

Author(s)
Aafia Afridi Department of Obstetrics and Gynecology, Hamza Surgical Hospital Peshawar, Pakistan
Muhammad Ayub Khan Chughtai Medical Centre, Lahore, Pakistan.
Sarfaraz Khan Mercy Teaching Hospital, Peshawar, Pakistan.
Haseeb Khaliq Federal Postgraduate Medical Institute, Lahore, Pakistan.
Tasneem Azhar Independent University Hospital, Faisalabad, Pakistan
Ehsan Khan University of Health Sciences Lahore, Pakistan
Abstract
Objective: To investigate Polycystic ovary syndrome (PCOS) associated pathologies in term of decreased BDNF levels. Methodology: Serum BDNF levels were quantified using Enzyme Linked Immunosorbent Assay (ELISA) from collected serum and follicular fluid samples from 100 PCOS patients and 60 healthy women as control. Results: BDNF both in the serum (08 ng/ml) and in the follicular fluid (10ng/ml) of PCOS patients was lower in comparison to the control group (serum 25ng/ml, Follicular 17ng/ml) with statistical significance (p<0.001). Hypo-BDNF state was significantly negative in follicular fluid as compared to serum. Conclusion: Chronic reduced BDNF levels in women with PCOS suggest that it can be used as a biomarker for disease severity and treatment efficacy. Low levels of BDNF may be in a causal relation to neuroendocrine and metabolic disturbances in PCOS.
Publication Details
Page(s) 125-127
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
polycystic ovary syndrome, BDNF, multi-system disorder., metabolic disorder
References
Deswal R,Narwal V,Dang A,Pundir CS .2020 .The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci, 13 : 261-71.
Ozgen Saydam B,Yildiz BO .2021 .Polycystic ovary syndrome and brain: an update on structural and functional studies. J Clin Endocrinol Metabol, 106 : e430-41.
Zhang Y,Chen D,Wang D,Wang L,Weng Y,Wang H .2022 .Moderate aerobic Exercise regulates follicular dysfunction by initiating brain-derived neurotrophic factor (BDNF)-Mediated anti-apoptotic signaling pathways in polycystic ovary syndrome. J Clin Med, 11 : 5584-8.
Anderson G .2024 .Polycystic ovary syndrome pathophysiology: integrating systemic, CNS and circadian processes. Front Biosci Landmark, 29 : 24-7.
Ghosh S,Dhar S,Bhattacharjee S,Bhattacharjee P .2023 .Contribution of environmental, genetic and epigenetic factors to obesity-related metabolic syndrome. The Nucleus, 66 : 215-37.
Hu Y,Wang W,Ma W,Wang W,Ren W,Wang S .2025 .Impact of psychological stress on ovarian function: Insights, mechanisms and intervention strategies. Int J Mol Med, 55 : 1-29.
Kim GM,Lee JA,Park SW,Lee JG,Jeon GH .2021 .Are plasma Brain-Derived Neurotrophic Factor or reproductive hormones related to depression in PCOS patients? A prospective cohort study. Clin Exp Obstet Gynecol, 48 : 1146-53.
Hong Z,Wu P,Zhuang H,Chen L,Hong S,Qin J .2024 .Prevalence of depression among women with polycystic ovary syndrome in mainland China: a systematic review and meta-analysis. BMC Psychiatry, 24 : 920-5.
Sarahian N,Sarvazad H,Sajadi E,Rahnejat N .2021 .Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review. Reprod Health, 18 : 156-9.
Chow R,Wessels JM,Foster WG JM .2020 .function in the mammalian reproductive Tract. Hum Reprod Update, 26 : 545-564.
Liu B,Liu Y,Li S,Chen P,Zhang J,Feng L. BDNF .2023 .promotes mouse follicular development and reverses ovarian aging by promoting cell proliferation. J Ovarian Res, 16 : 83-7.
Arosio B,Guerini FR,Voshaar RCO,Aprahamian I. Blood,Brain-Derived Neurotrophic I. Blood .2021 .Factor (BDNF) and Major Depression: Do We Have a Translational Perspective? Front Behav Neurosci. , 15 : 626906.
Zhang Q,Liu D,Zhang M,Li N,Lu S,Du Y .2016 .Effects of brain-derived neurotrophic factor on oocyte maturation and embryonic development in a rat model of polycystic ovary syndrome. Reprod Fertil Dev, : 1904-15.
Jacobsen VM,Li S,Wang A,Zhu D,Liu M,Thomassen M .2019 .Epigenetic association analysis of clinical subphenotypes in patients with polycystic ovary syndrome (PCOS). Gynecol Endocrinol, 35 : 691-4.
Wang F,Xie N,Zhou J,Dai M,Zhang Q,Hardiman PJ .2020 .Molecular mechanisms underlying altered neurobehavioural development of female offspring of mothers with polycystic ovary syndrome: FOS-mediated regulation of neurotrophins in placenta. E Bio Medicine, 60 : 102993.
Escobar-Morreale HF .2018 .Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol, 14 : 270-284.
Kim GM,Lee JA,Park SW,Lee JG,Jeon GH .2021 .Are plasma Brain-Derived Neurotrophic Factor or reproductive hormones related to depression in PCOS patients? A prospective cohort study. Clin Exp Obstet Gynecol, 48 : 1146-53.
Robeva R,Elenkova A,Kirilov G,Zacharieva S. .2023 .Plasmafree metanephrines, nerve growth factor, and renalase significance in patients with PCOS. Endocrine, 81 : 602-12.
Alfatlawy NK,AL-Taee HA,Rahim AI .2020 .A Comparative Study of Nerve Growth Factor Level in the Follicular Fluid of Polycystic and Non-Polycystic Ovary Syndrome Women Undergoing ICSI: a Cross-sectional Study. Indian J Forensic Med Toxicol, 14 : 2794-9.
Haddad-Filho H,Tosatti JA,Vale FM,Gomes KB,Reis FM .2023 .Updates in diagnosing polycystic ovary syndromerelated infertility. Expert Rev Mol Diagn, 23 : 123-32.
Ananthasubramanian P,Ananth S,Kumaraguru S,Barathi S,Santosh W,Vasantharekha R .2021 .Associated effects of endocrine disrupting chemicals (EDCs) on neuroendocrine axes and neurotransmitter profile in polycystic ovarian syndrome condition. Proc Zool Soc, 74 : 378-86.
Chow R,Wessels JM,Foster WG JM .2020 .function in the mammalian reproductive tract. Hum Reprod Update, 26 : 545-64.
Sarahian N,Sarvazad H,Sajadi E,Rahnejat N .2021 .Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: A narrative review. Reprod Health, 18 : 156-9.
Sobczuk J,Paczkowska K,Andrusiów S,Bolanowski M,Daroszewski J. Are M .2024 .Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with AmyloidBeta Aggregation. Biomolecules, 14 : 918-23.
0

Citations

0

Downloads

57

Views